Supply Agreements: Key Considerations as a Buyer
Thursday 18th November 2021
Key considerations as a buyer from the manufacturing and legal perspective
Since the start of the Covid-19 pandemic supply contracts have been under the spotlight as never before. Manufacturing deals have been closed between major pharma companies in record times, but not surprisingly as often happens for novel products, supply difficulties have arisen.
The AstraZeneca team will share their insights and experiences in this critical area of business.
Brian Dell, Operations BD Director
Nidhi Jain, Director Operations Procurement
Adam MacArthur, Assistant General Council, Digital, IT & Operations
Mike Stiles, Operations BD Director
£250 (Members: £225.00)